Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Roivant Sciences Ltd.SHS(ROIV) | 8,166,047 | 8,166,047 | 0 | $177.20M | $226.20M | 40.13% | +$49.00M |
| argenx SEADR(ARGX) | 26,000 | 36,718 | +10,718 | $21.86M | $26.81M | 4.76% | +$4.95M |
| Insmed Incorporated(INSM) | 267,000 | 157,500 | -109,500 | $46.47M | $25.75M | 4.57% | -$20.71M |
| BeOne Medicines AGADS(ONC) | 69,312 | 80,542 | +11,230 | $21.06M | $23.92M | 4.24% | +$2.86M |
| Cogent Biosciences, Inc.(COGT) | 317,372 | 596,000 | +278,628 | $11.27M | $22.94M | 4.07% | +$11.67M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 298,682 | 230,000 | -68,682 | $23.59M | $21.25M | 3.77% | -$2.35M |
| Belite Bio, IncADS(BLTE) | 0 | 116,684 | +116,684 | $0 | $18.60M | 3.30% | +$18.60M |
| Legend Biotech CorporationADS(LEGN) | 0 | 990,000 | +990,000 | $0 | $17.91M | 3.18% | +$17.91M |
| Nektar Therapeutics(NKTR) | 0 | 210,000 | +210,000 | $0 | $15.11M | 2.68% | +$15.11M |
| DBV Technologies S.A.ADS(DBVT) | 359,050 | 693,534 | +334,484 | $6.88M | $14.49M | 2.57% | +$7.60M |
| Pharvaris N V COM | 542,696 | 493,000 | -49,696 | $15.06M | $13.93M | 2.47% | -$1.13M |
| ABIVAX Société AnonymeADS(ABVX) | 130,000 | 121,245 | -8,755 | $17.53M | $13.50M | 2.40% | -$4.03M |
| Xenon Pharmaceuticals Inc.(XENE) | 136,500 | 227,000 | +90,500 | $6.12M | $13.20M | 2.34% | +$7.08M |
| Celcuity Inc.(CELC) | 120,000 | 95,000 | -25,000 | $11.97M | $10.84M | 1.92% | -$1.13M |
| EyePoint, Inc.(EYPT) | 780,000 | 795,000 | +15,000 | $14.25M | $10.25M | 1.82% | -$4.00M |
| Merck & Co., Inc.(MRK) | 0 | 80,000 | +80,000 | $0 | $9.62M | 1.71% | +$9.62M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 210,000 | 400,645 | +190,645 | $6.10M | $9.44M | 1.67% | +$3.34M |
| Allogene Therapeutics Inc | 4,963,756 | 3,450,000 | -1,513,756 | $6.80M | $8.42M | 1.49% | +$1.62M |
| Kymera Therapeutics, Inc.(KYMR) | 139,000 | 100,000 | -39,000 | $10.82M | $8.33M | 1.48% | -$2.49M |
| Dianthus Therapeutics, Inc.(DNTH) | 150,000 | 93,882 | -56,118 | $6.18M | $7.88M | 1.40% | +$1.70M |
| Enliven Therapeutics Inc | 308,141 | 200,000 | -108,141 | $4.75M | $7.84M | 1.39% | +$3.09M |
| Perspective Therapeutics, Inc.(CATX) | 1,132,815 | 1,625,000 | +492,185 | $3.12M | $6.78M | 1.20% | +$3.66M |
| Definium Therapeutics, Inc.(DFTX) | 0 | 331,000 | +331,000 | $0 | $6.26M | 1.11% | +$6.26M |
| Harrow, Inc.(HROW) | 7,031 | 165,209 | +158,178 | $344.5K | $5.83M | 1.03% | +$5.48M |
| Protara Therapeutics, Inc.(TARA) | 0 | 1,030,846 | +1,030,846 | $0 | $5.37M | 0.95% | +$5.37M |
| CytomX Therapeutics, Inc.(CTMX) | 0 | 1,085,790 | +1,085,790 | $0 | $5.10M | 0.91% | +$5.10M |
| Arcus Biosciences, Inc.(RCUS) | 170,000 | 195,000 | +25,000 | $4.05M | $4.21M | 0.75% | +$160.9K |
| Assembly Biosciences Inc | 127,000 | 136,315 | +9,315 | $4.32M | $3.78M | 0.67% | -$536.5K |
| Spyre Therapeutics, Inc.(SYRE) | 150,000 | 1,000 | -149,000 | $4.91M | $50.4K | 0.01% | -$4.86M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 350,000 | 0 | -350,000 | $4.23M | $0 | — | -$4.23M |
| Avalo Therapeutics, Inc.(AVTX) | 311,966 | 0 | -311,966 | $5.67M | $0 | — | -$5.67M |
| Disc Medicine, Inc.(IRON) | 74,000 | 0 | -74,000 | $5.88M | $0 | — | -$5.88M |
| Liquidia Corporation(LQDA) | 227,000 | 0 | -227,000 | $7.83M | $0 | — | -$7.83M |
| Ocular Therapeutix, Inc.(OCUL) | 490,000 | 0 | -490,000 | $5.95M | $0 | — | -$5.95M |
| Terns Pharmaceuticals Inc | 320,000 | 0 | -320,000 | $12.93M | $0 | — | -$12.93M |